PROCEPT BioRobotics (PRCT) Preferred Stock Liabilities (2020 - 2021)
PROCEPT BioRobotics (PRCT) posted quarterly Preferred Stock Liabilities of $328.6 million for Q2 2021, up 34.74% quarter-over-quarter from $243.9 million in Q1 2021.
PROCEPT BioRobotics (PRCT) Preferred Stock Liabilities (2020 - 2021) Analysis & Trends
PROCEPT BioRobotics (PRCT) has reported Preferred Stock Liabilities for 2 consecutive years, with $328.6 million the latest figure, recorded in Q2 2021.
- In Q2 2021, Preferred Stock Liabilities changed N/A year-over-year to $328.6 million; the TTM figure through Jun 2021 stood at $328.6 million (changed N/A YoY), while the FY2020 annual figure was $243.9 million, changed N/A from the prior year.
- Preferred Stock Liabilities climbed to $328.6 million in Q2 2021 per PRCT's latest filing, from $243.9 million in the prior quarter.
- Across five years, Preferred Stock Liabilities topped out at $328.6 million in Q2 2021 and bottomed at $243.9 million in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | - |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | - |
| 10 | PROCEPT BioRobotics | 1.20 Bn | 925.03 Mn | 62.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 328.56 Mn |
| Mar 31, 2021 | 243.85 Mn |
| Dec 31, 2020 | 243.85 Mn |
| Sep 30, 2020 | 243.85 Mn |